F S&P 500
5,359.00 +31.00 (+0.58%) F Dow Jones
39,821.00 +38.00 (+0.10%) F Nasdaq
18,972.00 +185.25 (+0.99%) E-mini Russell 2000 Index Futur
2,094.20 +5.10 (+0.24%) Petróleo
78.09 +0.52 (+0.67%) Oro
2,370.80 -22.10 (-0.92%)
Towa Pharmaceutical Co., Ltd. (TWAPF)
Towa Pharmaceutical Co., Ltd.
2-11, Shinbashi-cho
Kadoma
Osaka 571-8580
Japan
81 6 6900 9100
https://www.towayakuhin.co.jp
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Itsuro Yoshida | President & Representative Director | N/D | N/D | 1951 |
| Shiro Hatagami | Executive Officer & GM of Accounting and Finance Division | N/D | N/D | N/D |
| Shinya Kida | Operating Officer & GM of Administration Headquarters | N/D | N/D | N/D |
| Shigeki Fujita | Operating Officer & GM of Human Resource Development Center | N/D | N/D | N/D |
| Yutaka Okuda | Senior OO & Division Manager of R&D Division and Unit Manager of Innovative Tech Research Unit | N/D | N/D | N/D |
| Mr. Masao Tanaka | Director | N/D | N/D | 1954 |
| Mr. Norikazu Inoue | Senior Operating Officer & Director | N/D | N/D | 1959 |
| Mr. Osamu Uchikawa | Senior Operating Officer & Director | N/D | N/D | N/D |
| Tetsuro Tabata | Senior Operating Officers & Division Manager of Production Division | N/D | N/D | N/D |
Descripción
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.
Gestión corporativa
La calificación ISS Governance QuickScore de Towa Pharmaceutical Co., Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
